AAPL350.78-2.00 (-0.57%) ▼|ABBV293.17-1.39 (-0.47%) ▼|ABT105.84-1.61 (-1.50%) ▼|ACN241.03-6.67 (-2.69%) ▼|ADBE237.25-8.75 (-3.56%) ▼|AMAT344.15-6.11 (-1.74%) ▼|AMD489.82-14.47 (-2.87%) ▼|AMGN459.74-2.58 (-0.56%) ▼|AMT189.23-1.51 (-0.79%) ▼|AMZN256.70-1.05 (-0.41%) ▼|AVGO338.53+5.13 (+1.54%) ▲|AXP315.62-3.43 (-1.08%) ▼|BA164.60-0.62 (-0.38%) ▼|BAC49.24-0.84 (-1.68%) ▼|BKNG154.89-2.64 (-1.68%) ▼|BLK1,185.20-12.77 (-1.07%) ▼|BMY60.92-2.01 (-3.19%) ▼|BNY149.90-1.79 (-1.18%) ▼|BRK-B591.48-1.38 (-0.23%) ▼|C119.40-1.92 (-1.58%) ▼|CAT566.19-4.30 (-0.75%) ▼|CL100.35-0.64 (-0.63%) ▼|CMCSA25.59-0.02 (-0.06%) ▼|COF187.81-5.41 (-2.80%) ▼|COP141.20+0.68 (+0.48%) ▲|COST1,114.66+0.92 (+0.08%) ▲|CRM197.02-17.81 (-8.29%) ▼|CSCO94.94+0.42 (+0.44%) ▲|CVS86.54-2.05 (-2.31%) ▼|CVX216.46-0.68 (-0.31%) ▼|DE650.88-3.11 (-0.48%) ▼|DHR227.20-2.71 (-1.18%) ▼|DIS118.68-0.02 (-0.02%) ▼|DUK130.54-0.05 (-0.04%) ▼|EMR160.23-0.42 (-0.26%) ▼|FDX321.08-6.57 (-2.01%) ▼|GD357.52-2.18 (-0.60%) ▼|GE325.54+0.36 (+0.11%) ▲|GEV768.58+5.01 (+0.66%) ▲|GILD171.02+3.44 (+2.05%) ▲|GM84.24+0.63 (+0.75%) ▲|GOOG279.14-2.12 (-0.75%) ▼|GOOGL281.98-1.74 (-0.61%) ▼|GS877.40-14.14 (-1.59%) ▼|HD339.93-7.58 (-2.18%) ▼|HON221.82+3.87 (+1.78%) ▲|IBM233.41-9.10 (-3.75%) ▼|INTC54.04-1.40 (-2.53%) ▼|INTU327.00-18.56 (-5.37%) ▼|ISRG432.60-5.15 (-1.18%) ▼|JNJ279.69-2.86 (-1.01%) ▼|JPM330.55-7.67 (-2.27%) ▼|KO99.24-0.25 (-0.25%) ▼|LIN522.47-0.99 (-0.19%) ▼|LLY1,415.99-15.68 (-1.10%) ▼|LMT590.15+4.94 (+0.84%) ▲|LOW223.15-1.79 (-0.79%) ▼|LRCX208.72-2.11 (-1.00%) ▼|MA649.67-12.04 (-1.82%) ▼|MCD277.11+2.44 (+0.89%) ▲|MDLZ67.49-0.06 (-0.08%) ▼|MDT103.14+0.26 (+0.25%) ▲|META622.83-3.58 (-0.57%) ▼|MMM181.87+0.19 (+0.10%) ▲|MO78.16-0.75 (-0.94%) ▼|MRK144.11-0.36 (-0.25%) ▼|MS183.37-2.21 (-1.19%) ▼|MSFT503.42-14.58 (-2.81%) ▼|MU701.73-17.30 (-2.41%) ▼|NEE85.07-0.27 (-0.32%) ▼|NFLX59.68-1.07 (-1.76%) ▼|NKE37.32-0.95 (-2.47%) ▼|NOW93.10-6.27 (-6.31%) ▼|NVDA153.92-2.22 (-1.42%) ▼|ORCL114.48-4.61 (-3.87%) ▼|PEP143.64-2.79 (-1.91%) ▼|PFE28.51-0.36 (-1.23%) ▼|PG172.95-0.08 (-0.04%) ▼|PLTR156.81-3.58 (-2.23%) ▼|PM196.99+0.95 (+0.48%) ▲|QCOM167.13-1.39 (-0.82%) ▼|RTX197.32+2.43 (+1.25%) ▲|SBUX108.31-0.41 (-0.38%) ▼|SCHW91.20-1.75 (-1.88%) ▼|SO93.97-0.68 (-0.71%) ▼|SPG232.09-0.69 (-0.30%) ▼|T22.54+0.18 (+0.78%) ▲|TMO690.62-0.71 (-0.10%) ▼|TMUS170.21+0.20 (+0.12%) ▲|TSLA380.51+0.77 (+0.20%) ▲|TXN294.97+0.76 (+0.26%) ▲|UBER69.29-0.70 (-1.00%) ▼|UNH396.23-15.79 (-3.83%) ▼|UNP299.89-3.82 (-1.26%) ▼|UPS110.96-0.86 (-0.77%) ▼|USB59.45-0.98 (-1.62%) ▼|V419.49-6.97 (-1.63%) ▼|VZ46.33-0.01 (-0.02%) ▼|WFC82.89-1.95 (-2.30%) ▼|WMT127.83-0.58 (-0.45%) ▼|XOM167.44+0.57 (+0.34%) ▲|AAPL350.78-2.00 (-0.57%) ▼|ABBV293.17-1.39 (-0.47%) ▼|ABT105.84-1.61 (-1.50%) ▼|ACN241.03-6.67 (-2.69%) ▼|ADBE237.25-8.75 (-3.56%) ▼|AMAT344.15-6.11 (-1.74%) ▼|AMD489.82-14.47 (-2.87%) ▼|AMGN459.74-2.58 (-0.56%) ▼|AMT189.23-1.51 (-0.79%) ▼|AMZN256.70-1.05 (-0.41%) ▼|AVGO338.53+5.13 (+1.54%) ▲|AXP315.62-3.43 (-1.08%) ▼|BA164.60-0.62 (-0.38%) ▼|BAC49.24-0.84 (-1.68%) ▼|BKNG154.89-2.64 (-1.68%) ▼|BLK1,185.20-12.77 (-1.07%) ▼|BMY60.92-2.01 (-3.19%) ▼|BNY149.90-1.79 (-1.18%) ▼|BRK-B591.48-1.38 (-0.23%) ▼|C119.40-1.92 (-1.58%) ▼|CAT566.19-4.30 (-0.75%) ▼|CL100.35-0.64 (-0.63%) ▼|CMCSA25.59-0.02 (-0.06%) ▼|COF187.81-5.41 (-2.80%) ▼|COP141.20+0.68 (+0.48%) ▲|COST1,114.66+0.92 (+0.08%) ▲|CRM197.02-17.81 (-8.29%) ▼|CSCO94.94+0.42 (+0.44%) ▲|CVS86.54-2.05 (-2.31%) ▼|CVX216.46-0.68 (-0.31%) ▼|DE650.88-3.11 (-0.48%) ▼|DHR227.20-2.71 (-1.18%) ▼|DIS118.68-0.02 (-0.02%) ▼|DUK130.54-0.05 (-0.04%) ▼|EMR160.23-0.42 (-0.26%) ▼|FDX321.08-6.57 (-2.01%) ▼|GD357.52-2.18 (-0.60%) ▼|GE325.54+0.36 (+0.11%) ▲|GEV768.58+5.01 (+0.66%) ▲|GILD171.02+3.44 (+2.05%) ▲|GM84.24+0.63 (+0.75%) ▲|GOOG279.14-2.12 (-0.75%) ▼|GOOGL281.98-1.74 (-0.61%) ▼|GS877.40-14.14 (-1.59%) ▼|HD339.93-7.58 (-2.18%) ▼|HON221.82+3.87 (+1.78%) ▲|IBM233.41-9.10 (-3.75%) ▼|INTC54.04-1.40 (-2.53%) ▼|INTU327.00-18.56 (-5.37%) ▼|ISRG432.60-5.15 (-1.18%) ▼|JNJ279.69-2.86 (-1.01%) ▼|JPM330.55-7.67 (-2.27%) ▼|KO99.24-0.25 (-0.25%) ▼|LIN522.47-0.99 (-0.19%) ▼|LLY1,415.99-15.68 (-1.10%) ▼|LMT590.15+4.94 (+0.84%) ▲|LOW223.15-1.79 (-0.79%) ▼|LRCX208.72-2.11 (-1.00%) ▼|MA649.67-12.04 (-1.82%) ▼|MCD277.11+2.44 (+0.89%) ▲|MDLZ67.49-0.06 (-0.08%) ▼|MDT103.14+0.26 (+0.25%) ▲|META622.83-3.58 (-0.57%) ▼|MMM181.87+0.19 (+0.10%) ▲|MO78.16-0.75 (-0.94%) ▼|MRK144.11-0.36 (-0.25%) ▼|MS183.37-2.21 (-1.19%) ▼|MSFT503.42-14.58 (-2.81%) ▼|MU701.73-17.30 (-2.41%) ▼|NEE85.07-0.27 (-0.32%) ▼|NFLX59.68-1.07 (-1.76%) ▼|NKE37.32-0.95 (-2.47%) ▼|NOW93.10-6.27 (-6.31%) ▼|NVDA153.92-2.22 (-1.42%) ▼|ORCL114.48-4.61 (-3.87%) ▼|PEP143.64-2.79 (-1.91%) ▼|PFE28.51-0.36 (-1.23%) ▼|PG172.95-0.08 (-0.04%) ▼|PLTR156.81-3.58 (-2.23%) ▼|PM196.99+0.95 (+0.48%) ▲|QCOM167.13-1.39 (-0.82%) ▼|RTX197.32+2.43 (+1.25%) ▲|SBUX108.31-0.41 (-0.38%) ▼|SCHW91.20-1.75 (-1.88%) ▼|SO93.97-0.68 (-0.71%) ▼|SPG232.09-0.69 (-0.30%) ▼|T22.54+0.18 (+0.78%) ▲|TMO690.62-0.71 (-0.10%) ▼|TMUS170.21+0.20 (+0.12%) ▲|TSLA380.51+0.77 (+0.20%) ▲|TXN294.97+0.76 (+0.26%) ▲|UBER69.29-0.70 (-1.00%) ▼|UNH396.23-15.79 (-3.83%) ▼|UNP299.89-3.82 (-1.26%) ▼|UPS110.96-0.86 (-0.77%) ▼|USB59.45-0.98 (-1.62%) ▼|V419.49-6.97 (-1.63%) ▼|VZ46.33-0.01 (-0.02%) ▼|WFC82.89-1.95 (-2.30%) ▼|WMT127.83-0.58 (-0.45%) ▼|XOM167.44+0.57 (+0.34%) ▲|
13.9 C
New York
Tuesday, November 17, 2026

Tag: FOR

Antengene Presents Latest Preclinical Results of Novel Cos-TCE Platform AnTenGager‑D2 in Rapid Oral Abstract Presentation at SITC 2026

SHANGHAI and HONG KONG, Nov. 8, 2026 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to...

5 Biotech Stocks I’d Confidently Buy Today — And You Can Too

Okay besties, we're talking biotech today — five stocks with real long-term potential, and I'm breaking it down like we're chatting over iced lattes. Let's...

Innovent Announces Phase 3 CREDIT-5 Study Met Primary Endpoint, SINTBILO® (Tafolecimab Injection) as First-line Monotherapy Treatment for Hyperlipidemia Demonstrated Potent Lipid-lowering Efficacy

SINTBILO®  (tafolecimab injection) monotherapy achieved significant reduction of LDL-C level, with > 60% mean LDL-C reduction after 12 weeks of treatment with 150 mg...

Roche opens up new possibilities for genomic research in Asia Pacific with next-generation sequencing technology

AXELIOS 1 introduces Roche's proprietary sequencing by expansion (SBX) technology, designed for flexibility and performance to tackle a wide range of sequencing workflows with...

Roche opens up new possibilities for genomic research in Asia Pacific with next-generation sequencing technology

AXELIOS 1 introduces Roche's proprietary sequencing by expansion (SBX) technology, designed for flexibility and performance to tackle a wide range of sequencing workflows with...

Momcozy Unlocks Easier Motherhood with Black Friday Deals for Australian Mums

From smarter pumping solutions to easier feeding routines and summer-ready essentials, Momcozy empowers Australian mums to unlock an easier mode of motherhood this Black...

Fibocom LTE Cat.1 bis Modules: Starlink DTC Field Test Report

AUCKLAND, New Zealand, Nov. 8, 2026 /PRNewswire/ -- Fibocom's LE270-EU and LE271-GL LTE Cat.1 bis modules have successfully connected to the SpaceX Direct to...

Budget 2026: Masters of our Destiny – Minister Miller announces the rollout of $600 million targeted support to Canada’s audio and audiovisual sectors

As announced in Budget 2026, the Government of Canada is providing important measures to support the audio and audiovisual sectors, and to protect access...

Novo post hoc analysis finds Wegovy® 2.4 mg was associated with improvements in liver markers in adults with MASH with liver scarring and a...

A post hoc analysis of adults with MASH and liver scarring with a BMI below 27 kg/m² found that measures of liver injury, fibrosis,...

Allergan Aesthetics Reports Improved Satisfaction With Facial Appearance Following Aesthetic Treatment in Two Studies of Patients on GLP-1 Medications

– HARMONY IN DIVERSITY is the first study of combined neurotoxin and filler treatment in adults on glucagon-like peptide-1 (GLP-1) medications. In this Phase...

Unused FSA Funds Forfeit? Steps to Recover Value Before Deadline

Health flexible spending accounts suffer from a structural flaw that most workplace benefits do not: the use-it-or-lose-it provision. Unspent balances, in many plans, revert...

Cleaner Bedroom Air May Help Manage Blood Sugar in Prediabetes

NEW YORK, Nov. 8, 2026 /PRNewswire/ -- Using portable filters to reduce exposure to air pollution during sleep may stabilize the large spikes in...

T&T brand Organic Roasted Black Soybeans recalled due to undeclared milk

OTTAWA, ON, Nov. 8, 2026 /CNW/ --  Product: Organic Roasted Black SoybeansIssue: Food - Allergen - MilkDistribution: Do not consume recalled products to which you are...

Johnson & Johnson reports 73% PSA response rate with investigational pasritamig-based immunotherapy combination in advanced prostate cancer

First-of-its-kind dual-antigen-targeted bispecific regimen of pasritamig and JNJ-9401 directed at two prostate cancer proteins, KLK2 and PSMA, using complementary signals to activate T cells against...

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsFOR